Protein C News and Research

RSS

Receptor structure-based virtual screening identifies a promising p38α inhibitor

Announcing a new publication for Acta Materia Medica journal. Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli.

27 Oct 2023

IU researchers play key roles in national consortium to study the use of Alzheimer's disease biomarkers

Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer's disease.

27 Oct 2023

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Researchers in São Paulo state, Brazil, have developed a low-cost anti-inflammatory hydrogel that in future could help treat chronic skin lesions such as those often seen in people with diabetes.

27 Oct 2023

Genetics and sedimentology combined to refine cyanobacteria biomarker diagnostics

Cyanobacteria are a key species in Earth's history, as they introduced atmospheric oxygen for the first time. The analysis of their evolution therefore provides important insights into the formation of modern aerobic ecosystems.

27 Oct 2023

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission.

27 Oct 2023

Common chemical label shields proteins from degradation

Researchers from the University of Bergen (UiB) have uncovered that proteins use a common chemical label as a shield to protect them from degradation, which in turn affects motility and aging.

27 Oct 2023

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

Previous reports have linked long-term air pollution exposure with accumulation of Alzheimer's disease-related brain plaques, but this is the first accumulated evidence that reducing pollution, especially fine particulates in the air and pollutants from the burning of fuel, is associated with lower risk of all-cause dementia and Alzheimer's disease.

27 Oct 2023

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

In the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the incredible potential of mass spectrometry proteomics in biomedical research.

From Bruker Daltonics 27 Oct 2023

The differential effects of low-carb diet and habitual diet on the fecal level of short-chain fatty acid

The fecal levels of short-chain fatty acid (SCFA) and serum inflammatory markers.

27 Oct 2023

AI-designed drug candidate shows promise for gastric acid inhibition

Researchers at Nagoya University in Japan created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity than existing drugs.

26 Oct 2023

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

26 Oct 2023

Malaria protein discovery opens new avenues for combating deadly infection

The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite's immune evasion tactics could pave the way for new vaccines or therapeutics to combat the deadly infection.

26 Oct 2023

Exploring the link between red meat intake and inflammation

Inflammation is a risk factor for many chronic diseases, including cardiovascular disease (CVD), and the impact of diet on inflammation is an area of growing scientific interest.

26 Oct 2023

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

26 Oct 2023

Discovery of protein interaction could lead to new schizophrenia treatments

The discovery of a physical interaction between two proteins in brain cells that can be traced in mice to control of movement, anxiety and memory could one day open the door to development of new schizophrenia treatment strategies, researchers say.

26 Oct 2023

Healthy eating may be a key player in COPD risk reduction

The association between diet quality and the odds of Chronic obstructive pulmonary disease (COPD).

26 Oct 2023

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

Research paper provides a comprehensive review of per- and polyfluoroalkyl substances (PFAS), exploring their environmental prevalence, human exposure risks, and liver toxicity. The study highlights urgent gaps in PFAS research and calls for more studies to better understand these 'forever chemicals' and their impact on human health.

26 Oct 2023

Protein C News and Research

Receptor structure-based virtual screening identifies a promising p38α inhibitor

IU researchers play key roles in national consortium to study the use of Alzheimer's disease biomarkers

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Genetics and sedimentology combined to refine cyanobacteria biomarker diagnostics

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

Common chemical label shields proteins from degradation

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

The differential effects of low-carb diet and habitual diet on the fecal level of short-chain fatty acid

AI-designed drug candidate shows promise for gastric acid inhibition

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

Malaria protein discovery opens new avenues for combating deadly infection

Exploring the link between red meat intake and inflammation

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

Discovery of protein interaction could lead to new schizophrenia treatments

Healthy eating may be a key player in COPD risk reduction

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

New study aims to discover whether insomnia treatment can reduce cardiovascular disease risks

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News